Sign in or register to access exclusive content on this site
REGISTER

Publication: Symptoms and impact of aromatic L-amino acid decarboxylase (AADC) deficiency: A qualitative study and the development of a patient-centred conceptual model

This original study article, published in the Current Medical Research and Opinion journal outlines the first qualitative study to understand the symptoms of AADC deficiency and its impact on individuals’ health-related quality of life

  • Gain an insight into the symptoms, impact, and challenges experienced by individuals with AADC deficiency from the perspective of caregivers
  • Understand the range of symptoms and functional impairments experienced by individuals with AADC deficiency, and the impact these have on their daily life and health-related quality of life
  • Learn about potential approaches to treatment that may affect function and symptoms and therefore improve the daily lives and health-related quality of life of these individuals

Williams K, et al. Curr Med Res Opin. 2021;37:1353–1361

Once registered, you will be able to view the abstract and be provided the DOI and PubMed links for this publication.

Fast-track access

Don't have an NPI number? Switch to manual verification
MED-US-CORP-2600009 | September 2026

Register now:

This field is for validation purposes and should be left unchanged.
  • This Website is intended only for healthcare professionals (“Website“), is operated by PTC Therapeutics. (together with its affiliates “PTC”). In order to access the restricted content on this Website:
* indicates a required field
Back to NPI verification
MED-US-CORP-2600009 | September 2026
MED-US-AADC-2600007 | February 2026

Welcome to MEDhub

A website for healthcare professionals, provided by PTC Therapeutics

This educational website provides you with the latest scientific data and expert insights on the diagnosis and management of a range of rare diseases across the neuromuscular system, central nervous system, and other areas

This website may include scientific information about investigational and unlicensed products not approved for use within your country. Please refer to local regulatory guidance for country-specific information

© 2026 PTC Therapeutics. All rights reserved | MED-US-CORP-2600001 | February 2026

This content is protected.

To view it please enter your email address or NPI number below:

Register here to access the content on the site

MED-US-CORP-2600009 | September 2026

COMING SOON

The content you are trying to access is not currently available.

We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.